The Opioid Disruption with Medical Cannabis

Blockchain Technology is driving the legalization and regulation of the Cannabis Industry. Both are key booming industries with major innovations in terms of science and finance. 

What do the statistics say about the need for cannabis?

American Medical Association’s peer-reviewed journal reported that the opioid abuse is lower in states where the doctors have prescribed medical cannabis as pain relief. Previous studies have also shown that there is a reduction of opioid overdose deaths by almost 25% and non-fatal opioid hospitalization reduced by 23%. 

Surveys have shown that people who have access to medical cannabis have seen a reduction in popping pills. However, the opioid addiction still drains around $500 billion from US economy even after reduction caused by cannabis. So there is an urgent need to address the crisis and implement medical cannabis for treatment of chronic and acute diseases.

Even though cannabis and opioids have similar reactions with the brain with respect to pain relief, the molecules in cannabis(THC & CBD) have anti-inflammatory properties associated with pain. Though opioids are better at relieving the sensation of pain, cannabis improves in coping mechanisms and reduces the chances of addiction. 

Cannabis is a long-term solution with minimal side effects and zero chance of overdose. The users, medical professionals, and research scientists believe that medical cannabis can be the solution to replacing opioid addiction, however, lawmakers and certain sections of the population needs convincing. 

There are only a handful of companies that are researching on pharmaceutical preparations with cannabis. The advantage of the pharmaceutical preparation is that senior citizens, especially in assisted living facilities, can use cannabis medicines as an alternative to smoking. These might also appeal to the part of the population who think cannabis is a drug and with controlled pharmaceutical preparations, the likelihood of acceptance of cannabis as a medicine is higher.

In the era of the blockchain, with a handful of companies in the pharmaceutical preparations with medical cannabis. After a decade of research, the parent company of MCan Coin has developed their own genetically modified cannabis, Vichy Gold. 

Vichy Gold is highly sought after and has resulted in the current audited turnover of $60 million. With the cannabis market projected at $140 billion in  2027( 52% contributed by medical cannabis), MCan sees a growth of 10x in next 3 years. 

The potential of the medical cannabis market in the pharmaceutical preparation makes MCan, the only ICO in the cryptocurrency market with such a project. In addition, the team is backed by leading genetic engineers and a leadership team that is driven by innovation and financial know-how with an experience of taking companies to IPOs and listing them on NASDAQ, London Stock Exchange etc. 

The Pre-ICO begins on June 16th and the community will play a major role in the contribution to future of #CannabisingHealthcare. Join Telegram for more information :https://t.me/Medical_Cannabis_coin

 Follow us :

FaceBook : https://www.facebook.com/MCan-376613642846402/

Twitter : https://twitter.com/MedicalCannab

LinkedIn: https://www.linkedin.com/company/mcancoin/

Telegram: https://t.me/Medical_Cannabis_coin